Apellis Pharmaceuticals Inc (APLS)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

100 FIFTH AVENUE WALTHAM, MA 02451

Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. Leaders in targeted C3 therapies, the company aims to develop transformative therapies for a broad range of debilitating diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, nephrology, and neurology.

Data as of 2021-06-19 12:37:25 -0400
Market Cap4.839 Billion Shares Outstanding80.497 Million Avg 30-day Volume679.291 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-8.22 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.19378 52-week High/Low65.67 / 25.49 Next Earnings Date2021-07-29 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from APLS instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 4 6 -33.33% 1 (0.06%) 3 (0.17%) -66.67%
Funds Holding: 170 167 1.8% 61 (3.58%) 59 (3.42%) 3.39%
13F shares: 64.47 Million 63.85 Million 0.97% 33.788 Million 34.066 Million -0.82%
% Ownership 80.2115 84.3053 -4.86% 42.0374 44.9796 -6.54%
New Positions: 28 37 -24.32% 15 15 0.0%
Increased Positions 53 49 8.16% 15 11 36.36%
Closed Positions 23 13 76.92% 13 9 44.44%
Reduced Positions 61 60 1.67% 23 24 -4.17%
Total Calls 545.575 Thousand 286.072 Thousand 90.71% 211.3 Thousand 45.5 Thousand 364.4%
Total Puts 168.377 Thousand 122.113 Thousand 37.89% 72.7 Thousand 42.3 Thousand 71.87%
PUT/CALL Ratio 0.31 0.43 -27.91% 0.34 0.93 -63.44%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding APLS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding APLS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

195.4 Thousand total shares from 23 transactions

Exercise Derivative Conversion (M)

82.4 Thousand total shares from 14 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MACHIELS ALEC

  • Director
814,023 2021-06-15 12

DELONG MARK JEFFREY SENIOR VICE PRESIDENT

  • Officer
53,490 2021-06-15 3

GROSSI FEDERICO CHIEF MEDICAL OFFICER

  • Officer
54,930 2021-06-14 23

PERRY NICOLE D VICE PRESIDENT - ACCOUNTING

  • Officer
39,008 2021-06-11 10

SCHEIBLER LUKAS CHIEF INNOVATION OFFICER

  • Officer
26,651 2021-06-10 4

SULLIVAN TIMOTHY EUGENE CHIEF FINANCIAL OFFICER

  • Officer
432,760 2021-06-08 3

DUNLOP A. SINCLAIR

  • Director
376,469 2021-06-01 7

WATSON DAVID O. GENERAL COUNSEL

  • Officer
109,193 2021-05-28 7

DESCHATELETS PASCAL CHIEF SCIENTIFIC OFFICER

  • Officer
1,244,836 2021-05-24 6

BROWN VICTORIA L. PROGRAM TEAM LEAD

  • Officer
9,952 2021-03-25 5

EISELE JEFFREY EXEC VP, PROGRAM TEAM LEAD

  • Officer
14,961 2021-03-01 4

FRANCOIS CEDRIC CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
1,454,244 2021-02-10 12

TOWNSEND ADAM J. CHIEF COMMERCIAL OFFICER

  • Officer
18,865 2021-02-10 2

LEWIS KAREN CHIEF PEOPLE OFFICER

  • Officer
6,250 2021-01-28 1

NICHOLSON NUR CHIEF TECHNICAL OFFICER

  • Officer
9,375 2021-01-28 2

CHAN GERALD

  • Director
0 2021-01-01 1

O'BRIEN STEPHANIE MONAGHAN

  • Director
0 2021-01-01 1

FONTEYNE PAUL R.

  • Director
0 2021-01-01 1

LACKNER THOMAS A. SEE REMARKS

  • Officer
7,725 2020-02-10 0

SADR AHMAD SEE REMARKS

  • Officer
2,725 2020-02-10 0

CELONA LUCIA SEE REMARKS

  • Officer
5,213 2020-02-10 0

MORNINGSIDE VENTURE INVESTMENTS LTD

  • 10% Owner
12,556,342 2020-01-13 0

AXON STEVEN CHIEF BUSINESS OFFICER

  • Officer
50,110 2018-11-14 0

AJU IB INVESTMENT CO., LTD.

  • 10% Owner
No longer subject to file 2017-11-13 0

VENBIO GLOBAL STRATEGIC FUND II L.P.

  • 10% Owner
No longer subject to file 2017-11-13 0

GELLERT MICHAEL E

  • 10% Owner
No longer subject to file 2017-11-13 0

HILLHOUSE CAPITAL MANAGEMENT, LTD.

  • 10% Owner
No longer subject to file 2017-11-13 0

CORMORANT ASSET MANAGEMENT, LLC

CHEN BIHUA

CORMORANT GLOBAL HEALTHCARE GP, LLC

CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

  • Director
  • 10% Owner
No longer subject to file 2017-11-13 0

CORMORANT ASSET MANAGEMENT, LLC

CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

CORMORANT PRIVATE HEALTHCARE FUND I, LP

CHEN BIHUA

  • Director
  • 10% Owner
0 2017-11-08 0

POTENTIA HOLDINGS, LLC

  • 10% Owner
3,826,601 2017-11-08 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

DELONG MARK JEFFREY - Officer SENIOR VICE PRESIDENT

2021-06-16 16:32:12 -0400 2021-06-15 S 4,000 $64.96 d 9,490 direct 0.5184 0.5184 2 0.0 1

MACHIELS ALEC - Director

2021-06-16 16:33:52 -0400 2021-06-15 S 2,500 $64.83 d 669,544 direct yes 0.5184 0.5184 2 0.0 1

DELONG MARK JEFFREY - Officer SENIOR VICE PRESIDENT

2021-06-16 16:32:12 -0400 2021-06-15 M 4,000 $15.52 a 13,490 direct 0.5184 0.5184 2 0.0 1

MACHIELS ALEC - Director

2021-06-16 16:33:52 -0400 2021-06-15 M 2,500 $2.67 a 672,044 direct yes 0.5184 0.5184 2 0.0 1

DELONG MARK JEFFREY - Officer SENIOR VICE PRESIDENT

2021-06-16 16:32:12 -0400 2021-06-15 M 4,000 d 44,000 direct

MACHIELS ALEC - Director

2021-06-16 16:33:52 -0400 2021-06-15 M 2,500 d 142,529 direct yes

GROSSI FEDERICO - Officer CHIEF MEDICAL OFFICER

2021-06-15 16:03:35 -0400 2021-06-14 S 500 $61.84 d 54,930 direct yes 0.1843 0.1843 2 0.0 1

PERRY NICOLE D - Officer VICE PRESIDENT - ACCOUNTING

2021-06-15 16:04:57 -0400 2021-06-11 M 1,000 d 34,161 direct

PERRY NICOLE D - Officer VICE PRESIDENT - ACCOUNTING

2021-06-15 16:04:57 -0400 2021-06-11 S 1,000 $61.56 d 4,847 direct 0.1843 0.1843 2 0.0 1

PERRY NICOLE D - Officer VICE PRESIDENT - ACCOUNTING

2021-06-15 16:04:57 -0400 2021-06-11 M 1,000 $3.20 a 5,847 direct 0.1843 0.1843 2 0.0 1

SCHEIBLER LUKAS - Officer CHIEF INNOVATION OFFICER

2021-06-11 16:07:21 -0400 2021-06-10 S 3,417 $60.00 d 26,651 direct -6.5485 0.0 1 -6.5485 2

SULLIVAN TIMOTHY EUGENE - Officer CHIEF FINANCIAL OFFICER

2021-06-09 16:06:00 -0400 2021-06-08 M 39,880 d 358,619 direct

SULLIVAN TIMOTHY EUGENE - Officer CHIEF FINANCIAL OFFICER

2021-06-09 16:06:00 -0400 2021-06-08 M 39,880 $10.03 a 74,141 direct 1.9865 -1.8224 6.5506 3 -2.003 5

DUNLOP A. SINCLAIR - Director see footnote

2021-06-02 16:23:46 -0400 2021-06-01 J 2,682 a 303,361 indirect 2.1455 8.904 8.904 6 0.0 1

PERRY NICOLE D - Officer VICE PRESIDENT - ACCOUNTING

2021-06-02 16:15:18 -0400 2021-06-01 M 1,000 d 8,161 direct yes

DUNLOP A. SINCLAIR - Director

2021-06-02 16:23:46 -0400 2021-06-01 J 13,108 a 73,108 direct 2.1455 8.904 8.904 6 0.0 1

PERRY NICOLE D - Officer VICE PRESIDENT - ACCOUNTING

2021-06-02 16:15:18 -0400 2021-06-01 S 1,000 $56.40 d 4,847 direct yes 2.1455 8.904 8.904 6 0.0 1

DUNLOP A. SINCLAIR - Director see footnote

2021-06-02 16:23:46 -0400 2021-06-01 J 31,855 d 0 indirect 2.1455 8.904 8.904 6 0.0 1

PERRY NICOLE D - Officer VICE PRESIDENT - ACCOUNTING

2021-06-02 16:15:18 -0400 2021-06-01 M 1,000 $3.76 a 5,847 direct yes 2.1455 8.904 8.904 6 0.0 1

WATSON DAVID O. - Officer GENERAL COUNSEL

2021-06-01 16:53:30 -0400 2021-05-28 M 489 d 1,443 direct

WATSON DAVID O. - Officer GENERAL COUNSEL

2021-06-01 16:53:30 -0400 2021-05-28 M 489 $4.31 a 97,750 direct -0.4095 4.683 4.683 6 -0.4095 2

DESCHATELETS PASCAL - Officer CHIEF SCIENTIFIC OFFICER

2021-05-25 16:01:02 -0400 2021-05-24 M 6,250 d 375,249 direct yes

DESCHATELETS PASCAL - Officer CHIEF SCIENTIFIC OFFICER

2021-05-25 16:01:02 -0400 2021-05-24 S 6,250 $47.40 d 869,587 direct yes 10.0619 8.2237 12.2291 4 0.0 1

DESCHATELETS PASCAL - Officer CHIEF SCIENTIFIC OFFICER

2021-05-25 16:01:02 -0400 2021-05-24 M 6,250 $2.67 a 875,837 direct yes 10.0619 8.2237 12.2291 4 0.0 1

DUNLOP A. SINCLAIR - Director see footnote

2021-05-20 16:53:10 -0400 2021-05-20 S 5,773 $48.10 d 31,855 indirect -1.3172 17.6667 18.9212 5 -1.3172 2

DUNLOP A. SINCLAIR - Director see footnote

2021-05-20 16:53:10 -0400 2021-05-19 S 7,612 $50.00 d 300,679 indirect -1.3172 17.6667 18.9212 5 -1.3172 2

DUNLOP A. SINCLAIR - Director see footnote

2021-05-20 16:53:10 -0400 2021-05-18 S 10,388 $53.50 d 309,091 indirect -1.3172 17.6667 18.9212 5 -1.3172 2

DUNLOP A. SINCLAIR - Director see footnote

2021-05-20 16:53:10 -0400 2021-05-18 S 36,387 $53.78 d 59,946 indirect -1.3172 17.6667 18.9212 5 -1.3172 2

DELONG MARK JEFFREY - Officer SENIOR VICE PRESIDENT

2021-05-19 16:04:09 -0400 2021-05-18 M 2,000 d 48,000 direct yes

DUNLOP A. SINCLAIR - Director see footnote

2021-05-20 16:53:10 -0400 2021-05-18 S 1,200 $52.01 d 319,479 indirect -1.3172 17.6667 18.9212 5 -1.3172 2

DUNLOP A. SINCLAIR - Director see footnote

2021-05-20 16:53:10 -0400 2021-05-18 S 14,216 $52.63 d 96,333 indirect -1.3172 17.6667 18.9212 5 -1.3172 2

DELONG MARK JEFFREY - Officer SENIOR VICE PRESIDENT

2021-05-19 16:04:09 -0400 2021-05-18 S 2,000 $55.00 d 9,490 direct yes -2.288 16.2002 16.2002 6 -3.5751 3

DUNLOP A. SINCLAIR - Director see footnote

2021-05-20 16:53:10 -0400 2021-05-18 S 800 $54.02 d 308,291 indirect -1.3172 17.6667 18.9212 5 -1.3172 2

DUNLOP A. SINCLAIR - Director see footnote

2021-05-20 16:53:10 -0400 2021-05-18 S 22,318 $54.57 d 37,628 indirect -1.3172 17.6667 18.9212 5 -1.3172 2

DUNLOP A. SINCLAIR - Director see footnote

2021-05-20 16:53:10 -0400 2021-05-18 S 64,179 $51.66 d 110,549 indirect -1.3172 17.6667 18.9212 5 -1.3172 2

DELONG MARK JEFFREY - Officer SENIOR VICE PRESIDENT

2021-05-19 16:04:09 -0400 2021-05-18 M 2,000 $15.52 a 11,490 direct yes -2.288 16.2002 16.2002 6 -3.5751 3

GROSSI FEDERICO - Officer CHIEF MEDICAL OFFICER

2021-05-18 16:06:16 -0400 2021-05-14 S 500 $45.39 d 55,430 direct yes 1.5139 7.1754 7.1754 6 -2.1153 4

MACHIELS ALEC - Director

2021-05-18 16:05:28 -0400 2021-05-14 M 2,500 $2.67 a 672,044 direct yes 1.5139 7.1754 7.1754 6 -2.1153 4

MACHIELS ALEC - Director

2021-05-18 16:05:28 -0400 2021-05-14 M 2,500 d 145,029 direct yes

MACHIELS ALEC - Director

2021-05-18 16:05:28 -0400 2021-05-14 S 2,500 $45.39 d 669,544 direct yes 1.5139 7.1754 7.1754 6 -2.1153 4

PERRY NICOLE D - Officer VICE PRESIDENT - ACCOUNTING

2021-05-04 16:14:19 -0400 2021-05-03 S 1,000 $50.73 d 4,847 direct -3.5485 -3.3202 24.0921 34.6752 28 -8.1552 8

GROSSI FEDERICO - Officer CHIEF MEDICAL OFFICER

2021-05-04 16:11:40 -0400 2021-05-03 S 600 $50.73 d 55,614 direct yes -3.5485 -3.3202 24.0921 34.6752 28 -8.1552 8

PERRY NICOLE D - Officer VICE PRESIDENT - ACCOUNTING

2021-05-04 16:14:19 -0400 2021-05-03 M 1,000 $3.76 a 5,847 direct -3.5485 -3.3202 24.0921 34.6752 28 -8.1552 8

PERRY NICOLE D - Officer VICE PRESIDENT - ACCOUNTING

2021-05-04 16:14:19 -0400 2021-05-03 M 1,000 d 9,161 direct

PERRY NICOLE D - Officer VICE PRESIDENT - ACCOUNTING

2021-05-03 17:40:59 -0400 2021-04-30 S 1,000 $50.00 d 4,847 direct yes -3.0382 -6.1569 20.1006 30.5835 29 -10.9457 9

PERRY NICOLE D - Officer VICE PRESIDENT - ACCOUNTING

2021-05-03 17:40:59 -0400 2021-04-30 M 1,000 $3.76 a 5,847 direct yes -3.0382 -6.1569 20.1006 30.5835 29 -10.9457 9

PERRY NICOLE D - Officer VICE PRESIDENT - ACCOUNTING

2021-05-03 17:40:59 -0400 2021-04-30 M 1,000 d 10,161 direct yes

DESCHATELETS PASCAL - Officer CHIEF SCIENTIFIC OFFICER

2021-04-29 17:11:20 -0400 2021-04-28 M 4,500 $2.67 a 869,587 direct -0.9276 -7.1048 28.0837 28.0837 31 -12.6505 11

DESCHATELETS PASCAL - Officer CHIEF SCIENTIFIC OFFICER

2021-04-29 17:11:20 -0400 2021-04-28 M 4,500 d 381,499 direct

DUNLOP A. SINCLAIR - Director

2021-04-26 18:00:25 -0400 2021-04-23 M 10,000 $14.00 a 60,000 direct -0.33 9.3509 29.3509 29.3509 31 -2.6183 14

DESCHATELETS PASCAL - Officer CHIEF SCIENTIFIC OFFICER

2021-04-26 18:02:33 -0400 2021-04-23 M 6,250 $2.67 a 871,337 direct yes -0.33 9.3509 29.3509 29.3509 31 -2.6183 14

DESCHATELETS PASCAL - Officer CHIEF SCIENTIFIC OFFICER

2021-04-26 18:02:33 -0400 2021-04-23 M 6,250 d 385,999 direct yes

DUNLOP A. SINCLAIR - Director

2021-04-26 18:00:25 -0400 2021-04-23 M 10,000 d 61,894 direct

DESCHATELETS PASCAL - Officer CHIEF SCIENTIFIC OFFICER

2021-04-26 18:02:33 -0400 2021-04-23 S 6,250 $46.13 d 865,087 direct yes -0.33 9.3509 29.3509 29.3509 31 -2.6183 14

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
APELLIS PHARMACEUTICALS INC APLS 2021-06-21 22:15:03 UTC -0.17 0.25 800000
APELLIS PHARMACEUTICALS INC APLS 2021-06-21 21:45:03 UTC -0.201 0.281 800000
APELLIS PHARMACEUTICALS INC APLS 2021-06-21 21:15:03 UTC -0.201 0.281 800000
APELLIS PHARMACEUTICALS INC APLS 2021-06-21 20:45:03 UTC -0.201 0.281 800000
APELLIS PHARMACEUTICALS INC APLS 2021-06-21 20:15:03 UTC -0.201 0.281 800000
APELLIS PHARMACEUTICALS INC APLS 2021-06-21 19:45:03 UTC -0.201 0.281 800000
APELLIS PHARMACEUTICALS INC APLS 2021-06-21 19:15:03 UTC -0.201 0.281 800000
APELLIS PHARMACEUTICALS INC APLS 2021-06-21 18:45:03 UTC -0.2014 0.2814 800000
APELLIS PHARMACEUTICALS INC APLS 2021-06-21 18:15:03 UTC -0.2014 0.2814 800000
APELLIS PHARMACEUTICALS INC APLS 2021-06-21 17:45:03 UTC -0.2014 0.2814 800000
APELLIS PHARMACEUTICALS INC APLS 2021-06-21 17:15:03 UTC -0.2014 0.2814 800000
APELLIS PHARMACEUTICALS INC APLS 2021-06-21 16:45:02 UTC -0.2155 0.2955 800000
APELLIS PHARMACEUTICALS INC APLS 2021-06-21 16:15:03 UTC -0.2155 0.2955 800000
APELLIS PHARMACEUTICALS INC APLS 2021-06-21 15:45:03 UTC -0.2155 0.2955 800000
APELLIS PHARMACEUTICALS INC APLS 2021-06-21 15:15:03 UTC -0.2155 0.2955 800000
APELLIS PHARMACEUTICALS INC APLS 2021-06-21 14:45:03 UTC -0.17 0.25 800000
APELLIS PHARMACEUTICALS INC APLS 2021-06-21 14:15:02 UTC -0.17 0.25 800000
APELLIS PHARMACEUTICALS INC APLS 2021-06-21 13:45:03 UTC -0.17 0.25 800000
APELLIS PHARMACEUTICALS INC APLS 2021-06-21 13:15:03 UTC -0.17 0.25 800000
APELLIS PHARMACEUTICALS INC APLS 2021-06-21 12:45:03 UTC -0.17 0.25 700000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Trust for Professional Managers- Convergence Market Neutral Fund APLS -2152.0 shares, $-66346.16 2020-08-31 N-PORT
FundVantage Trust- Gotham Master Neutral Fund APLS -192.0 shares, $-5792.64 2020-09-30 N-PORT
Morningstar Funds Trust- Morningstar Alternatives Fund APLS -6484.0 shares, $-287046.68 2021-01-29 N-PORT
Trust for Professional Managers- Convergence Long/Short Equity Fund APLS -639.0 shares, $-30780.63 2021-02-26 N-PORT
AMERICAN BEACON FUNDS- American Beacon SSI Alternative Income Fund APLS -20045.0 shares, $-860130.95 2021-03-31 N-PORT

Elevate your investments